Literature DB >> 159126

Suppression of proliferative response and lymphokine production during the progression of a spontaneous tumor.

L Varesio, M Giovarelli, S Landolfo, G Forni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 159126

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  6 in total

1.  Tumour-induced suppressor macrophages in rats: differences in their suppressive effects on the Con A and PHA responses.

Authors:  Y Mizushima; H T Wepsic; Y Yamamura; M A Desilva
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

Review 2.  Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives.

Authors:  Patrick Raber; Augusto C Ochoa; Paulo C Rodríguez
Journal:  Immunol Invest       Date:  2012       Impact factor: 3.657

Review 3.  Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives.

Authors:  Paulo C Rodríguez; Augusto C Ochoa
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

4.  Modulation of the immunosuppressive effects of splenic macrophages in Fischer rats bearing adenocarcinoma 13762.

Authors:  J Bonaventure; V N Nigam; C A Brailovsky
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

5.  Effects of the removal of adherent and phagocytic cells on the spleen cell lymphoproliferative response of tumor-bearing mice.

Authors:  A M Hyde; R B Stagg; R McEachron; R L Nutter
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

6.  Suppressor cells in the effector phase of autologous cytotoxic reactions in cancer patients.

Authors:  M Eura; T Maehara; T Ikawa; T Ishikawa
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.